Insmed (INSM) Times Interest Earned (2011 - 2026)
Insmed (INSM) recorded quarterly Times Interest Earned of -$7.63 in Q1 2026, up 50.82% quarter-over-quarter from -$15.52 in Q4 2025, and up 33.64% on a YoY basis from -$5.71 in Q1 2025.
Insmed (INSM) Times Interest Earned (2011 - 2026) Analysis & Trends
Insmed's Times Interest Earned history runs 16 years deep, the most recent figure standing at -$7.63 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 33.64% year-over-year to -$7.63; the TTM figure through Mar 2026 stood at -$14.0 (down 21.91% YoY), while the FY2025 annual figure was -$14.88, down 43.85% from the prior year.
- Times Interest Earned was -$7.63 for Q1 2026 at Insmed, up from -$15.52 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$6.91 in Q1 2024 to a low of -$38.08 in Q3 2022.
- Historically, Times Interest Earned has averaged -$14.37 across 5 years, with a median of -$11.42 in 2023.
- The sharpest annual moves came in 2022 and 2023: Times Interest Earned tumbled 313.31% in 2022, then surged 80.89% in 2023.
- A 5-year view of Times Interest Earned shows it stood at -$9.21 in 2022, then gained by 6.88% to -$8.58 in 2023, then slipped by 24.65% to -$10.69 in 2024, then plunged by 45.18% to -$15.52 in 2025, then surged by 50.82% to -$7.63 in 2026.
- The last three Times Interest Earned figures came in at -$7.63 (Q1 2026), -$15.52 (Q4 2025), and -$17.96 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -7.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.63 |
| Dec 31, 2025 | -15.52 |
| Sep 30, 2025 | -17.96 |
| Jun 30, 2025 | -14.73 |
| Mar 31, 2025 | -11.50 |
| Dec 31, 2024 | -10.69 |
| Sep 30, 2024 | -10.14 |
| Jun 30, 2024 | -13.58 |
| Mar 31, 2024 | -6.91 |
| Dec 31, 2023 | -8.58 |
| Sep 30, 2023 | -7.28 |
| Jun 30, 2023 | -11.42 |
| Mar 31, 2023 | -7.41 |
| Dec 31, 2022 | -9.21 |
| Sep 30, 2022 | -38.08 |
| Jun 30, 2022 | -26.31 |
| Mar 31, 2022 | -27.30 |
| Dec 31, 2021 | -8.73 |
| Sep 30, 2021 | -9.21 |
| Jun 30, 2021 | -8.58 |